The same effect of the mAb mixture was observed in two other HER2 overexpressing cell lines; the gastric cancer cell line NCI‐N87 and the breast cancer cell line SK‐BR‐3 (Fig. S5). This evidence concerns the gene ERBB2 and breast carcinoma.